DOCSLIB.ORG

Campaign Report and Trading Summary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Campaign Report and Trading Summary ######## CAMPAIGN REPORT AND TRADING SUMMARY JMP Associates APRIL 2016 Campaign Report Summary LifeSci Capital KOL Series- Acute Sensorineural Selected buy side firms that viewed the report titled "LifeSci Capital KOL Hearing Loss (Published 03/04/2016) Series- Acute Sensorineural Hearing Loss" 30-day readership summary Institutional Investors Shareholder Aisling Capital No KOL Series Views Akahi Capital Management, LLC No 4,000 Alliance Bernstein No Alta Partners No 3,500 3,431 Alyeska Investment Group Yes Aquilo Capital Management, Llc No 2,963 Ardsley Partners, L.P. No 3,000 Armistice Capital Fund LP No Aspire Capital Partners, Llc No 2,500 Athyrium Capital Mgmt. LLC No AWM Investment Company, Inc. No 2,000 Bailard, Inc. No Baker Bros. Advisors, LLC No 1,500 Balyasny Asset Management No BlackRock Inc. (BLK) No Burrage Capital Partners, LLC No 1,000 Citadel Investment Group, LLC No Consonance Capital Management L.P No 500 Deerfield Management Company No DoubleLine Capital LP No 0 Driehaus Capital Management, Inc. No Eagle Asset Management No LifeSci Average KOL EAM Investors LLC No Fidelity Management & Research Co. Yes First Manhattan Company No Foresite Capital No Fountain HP No Franklin Templeton Investments No LifeSci Advisors Campaign Report Selected Buy Side Views Continued Selected buy side firms that viewed the report titled "LifeSci Capital KOL Series- Acute Sensorineural Hearing Loss" Institutional Investors Shareholder Institutional Investors Shareholder Frontier Capital Management No Signet Healthcare Partners No Gilder Gagnon Howe & Company No Sofinnova Ventures Yes Granite Investment Partners, LLC No Sphera Fund Management No Healthcor Partners, LLC No T. Rowe Price No Highland Capital Management No Tang Capital Management, LLC No Ingalls & Snyder Asset Management No The Boston Company Asset Management, LLC No Ironwood Investment Management LLC No Venrock Associates No Jennison Associates LLC No Voya Financial No Juniper Investment Company Llc No Wasatch Advisors Incorporated Yes Kingdon Capital Management No Wellington Management Company No Knoll Capital Management, L.P. No Wells Capital Management No Lombard Odier Darier Hentsch No Woodstock Corporation No Longwood Investment Advisors No Goldman Sachs Asset Management No Millennium Management Llc No Opaleye Yes Opus Point Partners, LLC No Tocqueville Asset Management Yes Oracle Investment Management Inc No OrbiMed Advisers Inc. No Palo Alto Investors, LLC No Perceptive Advisors No Perella Weinberg Partners (PWP) No Pura Vida Investments No Putnam Investments Trust No Quogue Capital, LLC No QVT Financial LP No Redmile Group, LLC No Royce & Associates No LifeSci Advisors Campaign Report Selected Industry Insider and Sell Side Views Selected industry insiders that viewed the report titled Selected sell side firms that viewed the report titled "LifeSci Capital "LifeSci Capital KOL Series- Acute Sensorineural Hearing KOL Series- Acute Sensorineural Hearing Loss" Loss" Industry Insiders Sell Side Firms Coverage Brendan Downey, Novartis, brendan.downey@novartis.com Aegis Capital Corp. No Stefanie Hansen, Pfizer Inc., stefanie.a.hansen@pfizer.com American Portfolios Financial Svc No Jay Kranzler, Pfizer Inc., jay.kranzler@pfizer.com Robert W. Baird & Co. Inc. No John Hendrickson, Perrigo Company, john.hendrickson@perrigo.com Bank of America Corp. No Peter Boderke, Merz Pharma, peter.boderke@merz.de Barclays No Laura Reilly, Bayer Healthcare Pharmaceutica, laura.reilly@bayer.com Alliance Bernstein No Jerome Zeldis, Celgene Corp, jzeldis@celgene.com Bishop, Rosen & Co., Inc. No Stacy Coen, Genzyme Corporation, stacy.coen@genzyme.com Bloom Burton & Co. No John Mchutchison, Gilead Sciences, Inc, john.mchutchison@gilead.com BTIG, Inc No John Chung, Gilead Sciences, Inc, john.chung@rbccm.com Canaccord Genuity Corp. No Jeff Sherman, Horizon Pharma, jsherman@horizonpharma.com Chardan Capital Markets, LLC No Bob Carey, Horizon Pharma, bcarey@horizonpharma.com Citigroup, Inc. No Dominic Caruso, Johnson & Johnson, dcaruso@its.jnj.com Ramius Cowen Group, Inc. No Michael Holston, Merck & Co., Inc., michael.holston@merck.com Credit Suisse No Mariah Lopshire, Sanofi, mariah.lopshire@sanofi.com Crystal Research Associates Llc No Nicolas Schlumberger, Sanofi, nicolas.schlumberger@sanofi.com Dawson James Securities, Inc. No Yitzhak Peterburg, Teva., yitzhak.peterburg@tevapharm.com Deutsche Bank AG No Roni Shiloh, Teva, roni.shiloh@teva.co.il Edison Investment Research Limited No Ian Smith, Vertex Pharmaceuticals Inc, ian_smith@vrtx.com Fbr Capital Markets & Co. No ferghanapartners No First Analysis Securities Corporation No Griffin Securities Inc No Guggenheim Partners, LLC No Ifs Capital Markets No International Strategy and Investment Group No Invest Securities No LifeSci Advisors Campaign Report Selected Sell Side Views Continued Selected sell side firms that viewed the report titled "LifeSci Capital KOL Series- Acute Sensorineural Hearing Loss" Sell Side Firms Coverage Janney Montgomery Scott No JMP Associates Yes Ladenburg Thalmann & Co. Inc. No Lake Street Capital Markets Llc No Leerink Swann, LLC Yes Loeb Partners Corporation No Maxim Group, Llc No Morningstar No Natixis Global Associates No Needham & Company, Inc. Yes Oppenheimer & Company, LP No Piper Jaffray No Raymond James No RBC No Roth Capital Partners, Llc No Stifel No Summer Street Research Partners No SunTrust Banks, Inc. No Susquehanna Financial Group, LLLP No Washington Analysis No Wedbush Securities Inc No Wells Fargo & Company No William Blair & Company No LifeSci Advisors Campaign Report Selected Downloads Selected downloads for the report titled "LifeSci Capital KOL Series- Acute Sensorineural Hearing Loss" Name and Firm Email Tim Muller, CrossJect t.muller@crossject.com Laurent Nguyen, Sensorion Pharma laurent.nguyen@sensorion-pharma.com David Munno, Altimmune enright@vaxin.com Mia Marko, Novartis mia.marko@novartis.com Steve Urbach, Chardin stevenurback@sharton.com Neal Birnberg, MTI Pharma birnberg@mtipharm.com Junichi Hosono, Seikagaku junichi.hosono@seikagaku.co.jp Adam Podmore, University of Auckland a.podmore@auckland.ac.nz Daniela Fattori, Menarini Group dfattori@menarini-ricerche.it Patrick Rivelli, Abrams Capital, LLC rivelli@ix.netcom.com Margo Fuld, Aegis Capital Corp. mfuld@aegiscap.com Mario Deketelaere, Agfa Healthcare mario.deketelaere@skynet.be Greg Flesher, Avanir Pharmaceuticals gflesher@oticpharma.com Pascal PAUNOVIC, Belsize Asset Management GmbH pascal.paunovic@belsize-am.com Go Saito, Daiichi Sankyo Inc gsaito@dsi.com Bill Kridel, ferghanapartners kridel@ferghanapartners.com Andrew Stein, First Manhattan Company astein@firstmanhattan.com Philip Comby, Hottinger Capital pcomby@swz.com Investor Relations, Inovio Biomedical Corporation investor.relations@inovio.com Warren Isabelle, Ironwood Investment Management LLC wisabelle@ironwoodfunds.com Declan Daly, Isolagen Technologies Inc ddaly@isolagen.com Jeanne Bolger, Johnson & Johnson jbolger@its.jnj.com Ruchir Sharma, Morgan Stanley Investment Management kalorama3@yahoo.com Victor Clavelli, Pfizer Inc. victor.clavelli@pfizer.com G´è_nther Metz, Santhera Pharmaceuticals Holding AG guenther.metz@santhera.com Gary Jacob, Trovagene gjacob@trovagene.com Carl Janson, Zaramant Fonder AB carlharald.janson@zaramant.com Michael Nawrath, Zuercher Kantonalbank michael.nawrath@zkb.ch LifeSci Advisors Campaign Report Total Cumulative Return vs. BBC Comparison of Total Cumulative Return (EuCo US Equity vs BBC US EQUITY) 250 ######## 200 2/12/2015 urn t 2/13/2015 e 2/17/2015 R l 2/18/2015 a 150 2/19/2015 ot T 2/20/2015 e v 2/23/2015 i t 100 a 2/24/2015 l 2/25/2015 mu 2/26/2015 Cu 50 2/27/2015 3/2/2015 3/3/2015 0 3/4/2015 3/5/2015 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 3/6/2015 EuCo US Equity BBC US EQUITY Volume (EuCo US Equity) 8,000 y) 6,000 pan s 4,000 0' (Com JMP Associates 00 e 2,000 0 olum V Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 US Equity The Bioshares Biotechnology Clinical Trials Index (Nasdaq: BBC) comprised solely of pure-play biotechnology companies with an asset in Phase 1 to Phase 3 clinical trials and is therefore representative of the performance of the biotechnology companies with no approved products. Most biotechnology indexes include non-biotech companies and are dominated by large companies with approved products. The BBC should also reflect the volatility of clinical-stage companies, which is typically greater than those with approved products. LifeSci Advisors Campaign Report Short Interest EuroCo US Equity Short Interest % Float % Float Thousands Short Positions 4 2,500 K Avg Daily Volume Short Position 3.5 2,000 K 3 2.5 1,500 K 2 1,000 K 1.5 1 500 K 0.5 3/30/2016 0 K 10/30/2015 10/15/2015 9/30/2015 9/15/2015 8/31/2015 8/14/2015 7/31/2015 Days to Cover Short Interest Ratio 7/15/2015 20.00 6/30/2015 18.00 6/15/2015 16.00 5/29/2015 14.00 5/15/2015 12.00 4/30/2015 10.00 4/15/2015 8.00 6.00 4.00 2/27/2015 2.00 2/13/2015 0.00 1/30/2015 1/15/2015 12/31/2014 12/15/2014 11/28/2014 11/14/2014 10/31/2014 10/15/2014 9/30/2014 9/15/2014 8/29/2014 LifeSci Advisors Campaign Report 8/15/2014.
Load more

Recommended publications
  • 17-19 November 2020
    17-19 November 2020 https://financeusa.solarenergyevents.com Confirmed Organizations: 38 DEGREES NORTH EC CAPITAL NATURAL POWER CONSULTANTS AB POWER ADVISORS ECOS ENERGY NAUTILUS SOLAR ENERGY, LLC AETHER INVESTMENT PARTNERS EMERGING ENERGY & ENVIRONMENT INVESTMENT GROUP LLC NEW ENERGY EQUITY AGILITAS ENERGY, LLC ENBALANCE STORAGE NJR CLEAN ENERGY VENTURES AMARESCO ENCORE RENEWABLE ENERGY NORD LB AMERICAS ENERGY GROUP ENEL X NUVEEN, A TIAA COMPANY APRICITY RENEWABLES INC. ENERGY STORAGE DEVELOPMENT PARTNERS ONYX RENEWABLE PARTNERS, LP. ASCEND ANALYTICS ENERGY TOOLBASE ORIGIS ENERGY AVANA CAPITAL ENERVEST CAPITAL ORIGIS SERVICES BLACKROCK FTI CONSULTING PEAK POWER BLATTNER ENERGY GINLONG TECHNOLOGIES PIVOT ENERGY BLOOMBURG GLOBUS THENKEN POWER AFRICA-USAID BLUE WAVE SOLAR GRIDSME PV TECH RESEARCH BNRG HECATE ENERGY RABOBANK BORALEX HELIOLYTICS RADIENT REIT BOSTONIA PARTNERS HELIOVAAS RIGUP BRETTS SOLUTIONS HODGSON RUSS ROTH CAPITAL PARTNERS BRIGHTNIGHT INVESTEC HOLDINGS SEMINOLE FINANCIAL SERVICES BVT ITRI SILICON RANCH C2 ENERGY CAPITAL JAVELIN CAPITAL SOLAMERICA ENERGY CALVERT IMPACT CAPITAL JINKO SOLAR SOLAR RANCH DEVELOPMENT CENTROPLAN USA LLC KAISERWETTER ENERGY ASSET MANAGEMEMT SOLAR RANCH DEVELOPMENT COMPANY CIT BANK KEYBANC CAPITAL MARKETS SOLARIS GLOBAL LLC CITADEL LECLANCHE SOLAS ENERGY CONSULTING CLEAN HORIZON LIBERTY RENEWABLES SOLIS INVERTERS CLEANCAPITAL LIGHTSOURCE BP STANDARD SOLAR INC. CLIFFVIEW PARTNERS LIVE OAK BANK STARKPOINT CAPITAL ADVISORS, LLC CNB LONGI SOLAR STEM COMMONWEALTH BANK OF AUSTRALIA LS POWER SUNLIGHT GENERAL CAPITAL COMMUNITY ENERGY M&T BANK SUNTECH CONEDISON MAP ENERGY SUSGEN CPS ENERGY MARATHON CAPITAL SUSTAINABLE WESTCHESTER CUBICO MITSUBISHI HEAVY INDUSTRIES AMERICA, INC. TMEIC CUSTOMIZED ENERGY SOLUTIONS MOMENTUM ENERGY STORAGE PARTNERS TORTOISE ADVISORS DAYMARK ENERGY ADVISORS MONARCH PRIVATE CAPITAL U.S. DEPARTMENT OF ENERGY DLA PIPER MOTT MACDONALD UL DNV-GL MUNICHRE USAID/ POWER AFRICA.
    [Show full text]
  • Download IPO Report
    Donnelley Financial Solutions US IPO Report - December 2020 Edition Congratulations to the 74 December issuers and their advisors on the ~$159 Billion "2020 - an unforgettable year for IPOs! successful completion of their IPO. As I look back on all the successes we Total Raised in 2020 DFIN was proud to have serviced shared with our clients - perseverance, AbCellera Biologics, Altitude hard work, compassion, and great Acquisition, BioAtla, CBRE partnerships led us to successfully Acquisition, 17 Education & 2020 Priced (count) complete 197 IPOs during a year with Technology Group, 4D Molecular 100 so many challenges. An incredibly Therapeutics, Wish, DoorDash, active pipeline, robust valuations, Far Peak Acquisition, Golden vaccine deployment and newfound Falcon Acquisition, Gores hope brings much optimism for 2021." Holding VI, Marquee Raine CRAIG CLAY, PRESIDENT, DONNELLEY FINANCIAL SOLUTIONS 0 Acquisition, Periphas Capital JAN FEB MAR APR MAY JUNE JULY AUG SEP OCT NOV DE… Partnering, Pharming Group NV, Silverback Therapeutics, Thayer 91 League Table *Top 25 Ventures Acquisition, Upstart Issuer's Counsel Count Holdings, and the largest offering IPOs publicly filed in December Ellenoff Grossman 48 this year Airbnb! bringing total count for 2020 to 621. In Kirkland & Ellis 41 2019, there were 293 total filings and Skadden Arps 38 Latham & Watkins LLP 33 296 in 2018. 156 of 2020 filings are Cooley LLP 30 December Priced (count) pending pricing. Goodwin Procter 27 2017 (15) White & Case 23 Davis Polk 19 Sector Breakdown (non-SPACs) 2018 (17) Loeb & Loeb 16 Wilson Sonsini 16 49.8% Healthcare 2019 (13) Winston & Strawn 15 24.08% Technology Ropes & Gray 14 2020 (74) Weil Gotshal 14 11.42% Consumer 2020 Priced Simpson Thacher 11 7.35% Industrial Graubard Miller 9 Greenberg Traurig 9 7.35% Financial 50% of the priced IPOs in 2020 were Paul Weiss 7 SPACs with a total count for the year Sheppard Mullin 7 WilmerHale 7 248 with a total valuation of ~$76 Healthcare Fenwick & West 6 billion.
    [Show full text]
  • Dealflow Report the NEWS, INFORMATION, and ANALYSIS of SMALL CAP EQUITY FINANCE Volume I, No
    dealflow report THE NEWS, INFORMATION, AND ANALYSIS OF SMALL CAP EQUITY FINANCE Volume I, No. 38 report.dealflowmedia.comreport.dealflow.com October 8, 2012 SMALL CAP MARKETS SMALL CAP FINANCING PICKED • The small cap financing market picked up in the third quarter. UP IN THIRD QUARTER AS • China’s agreement with the PCAOB may not VOLATILITY DECLINED boost investment. by Dan Lonkevich • An SEC commissioner called for a Small cap and microcap financing activ- markets at Roth Capital Partners in New- comprehensive review of regulatory structure ...2 ity picked up in the third quarter as a less port Beach, Calif. “There’s a slight uplift • Sun River reached a settlement with three volatile stock market helped companies to from issuer stock prices. When they feel investors who accused it of fraud ........................3 feel better about their valuations. better about their stock price, they’re more Publicly traded companies made at least willing to do deals.” DATES & DEADLINES 246 private placements of equity in the Roth Capital helped arrange six PIPEs • A listing of important events coming up in the quarter, raising $11.2 billion. It was the worth $68.8 million in the third quarter. small cap financing market ...............................4 most active third quarter for the PIPE mar- Concerns about the upcoming presi- ket since 2008. dential election and uncertainty about how PIPEs In 2011’s third quarter, there were only the results might affect their businesses is • BioFuel Energy may need to raise capital ...........6 227 PIPEs that raised $11 billion. causing many companies to take advantage • Antares Pharma raised $50M for an arthritis The data excludes PIPEs that raised less of the recent uptick in their stock prices to drug ........................................................................6 than $1 million and transactions by for- raise capital now rather than waiting, Gure- • Cantor is providing a $45M ATM for Unilife .......7 eign companies that weren’t listed on U.S.
    [Show full text]
  • Aftermarket Research Source Book
    Aftermarket Research Source Book November 2020 Refinitiv Aftermarket research collections provide the most comprehensive offering in the marketplace, with over 30 million research reports from over 1,900 sources. This document provides an index of the available research sources across the following collections: Subscription / Investext® Collection Pay-Per-View (PPV) / Research Select and Market Research Collections Aftermarket Research Source Book - November 2020 2 New Contributors Added Year to Date 81 contributors from 34 countries have been added to the collection since the beginning of 2020 Australia 3 Ireland 1 South Africa 1 Brazil 1 Japan 4 South Korea 1 Canada 5 Kenya 2 Spain 2 Chile 1 Lebanon 1 Switzerland 1 China 4 Liechtenstein 1 Turkey 2 Colombia 1 Nigeria 4 United Arab Emirates 6 France 2 Peru 1 United Kingdom 5 Germany 1 Philippines 1 United States 11 Ghana 1 Russia 1 Uzbekistan 2 Hong Kong 6 Saudi Arabia 1 Vietnam 1 India 3 Singapore 2 Indonesia 1 Slovenia 1 Contributor Highlights Refinitiv is pleased to announce that BofA Global Research has joined the list of exclusive BofA Global Research contributors only accessible, by qualifying users, through our Aftermarket Research collection. • A team of 285 analysts covering approximately 3,100 companies in 24 global industries – one of the largest research providers worldwide and with more sector coverage than anyone else. • More coverage (2,832) in large- and mid-caps than bulge-bracket peers. • One of the largest producers of equity research with approximately 47,000 documents published in 2019. GraniteShares is an entrepreneurial ETF provider focused on providing innovative, cutting-edge alternative investment solutions.
    [Show full text]
  • Placementtracker Publishes PIPE Market League Tables
    Source: Sagient Research Systems PlacementTracker Publishes PIPE Market League Tables SAN DIEGO, July 23, 2007 (PRIME NEWSWIRE) -- Sagient Research Systems, a leading publisher of independent research for the financial services and institutional investment communities, today announced that Rodman & Renshaw, LLC ranked as the number one most active investment bank and Iroquois Capital, L.P. ranked as the number one most active institutional investor in the PIPE market during the first half of 2007. PlacementTracker also announced that Sichenzia Ross Friedman Ference, LLP ranked as the number one most active issuer counsel and Schulte Roth & Zabel, LLP ranked as the number one most active investor counsel in the PIPE market during the first two quarters of 2007. PlacementTracker, a flagship product of Sagient Research Systems, is well recognized as the leading provider of research, data, and analytics covering the PIPE market. Commenting on the League Tables, Robert F. Kyle, executive vice president of Sagient Research said, "The amount raised in the first half of 2007 was the largest ever in the history of the PIPE market. During the first six months, we recorded 645 PIPE transactions totaling $22.42 billion in equity and equity-linked capital raised (excluding Structured Equity Lines and Canadian issuers). Although the number of transactions dipped slightly versus the first half of last year, the amount raised represents an astounding 38% increase over the total amount raised during the first half of 2006 and puts the market on track to smash last year's record volume of PIPE activity. As always, we congratulate all of the active agents, investors, and legal counsel in the PIPE market for a tremendous first half, especially those leaders who topped the League Tables.
    [Show full text]
  • 3Q 2019 Contents Credits & Contact
    Global League Tables 3Q 2019 Contents Credits & contact PitchBook Data, Inc. Introduction 2 John Gabbert Founder, CEO Adley Bowden Vice President, PE firms 3-11 Market Development & Analysis Content VC firms 12-19 Garrett James Black Senior Advisors/accountants & investment banks 20-25 Manager, Custom Research & Publishing Law firms: VC & PE 26-35 Van Le Senior Data Analyst Acquirers 36-38 Contact PitchBook Research reports@pitchbook.com Cover design by Kelilah King Click here for PitchBook’s report methodologies. Introduction Thank you to all who participated in the surveys that firm for each given section), however, spacing and enable these rankings to be possible. Once again, near- aggregate tallies prevented us from adopting that cutoff record submissions led to this edition of the Global consistently on every page. All in all, we are confident League Tables being released somewhat later in the that the current tables will provide a useful, accurate quarter. As always at PitchBook, we prioritize accuracy snapshot of activity throughout 3Q 2019 by our array of above all else. We will continue to elect to provide the typical criteria, from venture transactions by stage to US most precise information over speed until we are sure we region. can accomplish both. Stay tuned for potential changes to these rankings as In this edition, we carried over our style of rankings, we continue to look for the most efficient and accurate which should prove helpful for quick consultation. We way to showcase the most active firms across private endeavored to keep the number of rankings equivalent markets. per page (e.g.
    [Show full text]
  • Demystifying the Private Equity Process
    Welcome To Taking “Capital” from “Private Capital”: Demystifying the Private Equity Process Contents Page Today’s Program .....................................................................................1 Key Considerations When Financing Your Growth Company ..........5 Growth Capital Letter of Intent ..............................................................13 Buyout Letter of Intent ...........................................................................19 Mezzanine Financing Letter of Intent ....................................................24 Due Diligence Lists .................................................................................29 Duane Morris Private Equity Attorneys ................................................45 INNOVATIONS @ HAND PRIVATE EQUITY DUANE MORRIS WELCOMES YOU TO Taking “Capital” from “Private Capital”: Demystifying the Private Equity Process Private equity investors have an edge: They routinely buy and sell companies according to their investment objectives. Business owners have their own advantages: They operate and grow businesses for a living and build assets private equity investors covet. In this give-and-take, who really has the upper hand? This informative, interactive edition of Duane Morris’ Connections Forum Series is where insiders from all sides of the buy-sell equation discuss some of the many questions faced by those engaged in, or considering, the middle-market buyout process. Panelists examine the factors of valuation and maximizing that value; the role of management teams;
    [Show full text]
  • Chinese Companies Listed on Major U.S. Stock Exchanges
    Last updated: May 5, 2021 Chinese Companies Listed on Major U.S. Stock Exchanges This table includes Chinese companies listed on the NASDAQ, New York Stock Exchange, and NYSE American, the three largest U.S. exchanges. i As of May 5, 2021, there were 248 Chinese companies listed on these U.S. exchanges with a total market capitalization of $2.1 trillion. On October 2, 2020, when this table was last updated, there were 217 companies with a total market capitalization of $2.2 trillion. In the list below, newly added companies are marked with a section symbol (§) next to the stock symbol. ii Companies are arranged by the size of their market cap. There are eight national-level Chinese state-owned enterprises (SOEs) listed on the three major U.S. exchanges. In the list below, SOEs are marked with an asterisk (*) next to the stock symbol. iii Since this table was last updated in October 2020, 17 Chinese companies have delisted. Two companies currently trade over the counter: Kingold Jewelry (KGJI, $3 million market cap) and state-owned Guangshen Railway (GSHHY, $2,256 million market cap). The 17 delisted companies also include four companies targeted by the Executive Order 13959 (“Addressing the Threat from Securities Investments That Finance Communist Chinese Military Companies”), which prohibited investment in Communist Chinese Military Companies. These are: China Unicom, China Telecom, China Mobile, and CNOOC Limited. In addition, Semiconductor Manufacturing International Corporation (SMIC) stopped trading over the counter as a result of the order.1 The remaining U.S.-listed company subject to the order is Luokung Technology Corp.
    [Show full text]
  • Placementtracker Publishes Q1 2021 PIPE and Private Placement Markets League Tables
    PlacementTracker Publishes Q1 2021 PIPE and Private Placement Markets League Tables PlacementTracker, the leading source for data and analysis to institutions in the PIPE and Private Placement markets, today announced the most active investment banks, investors, and law firms in the U.S. PIPE and Private Placement markets for Q1 2021. A total of $66 billion was raised in 699 transactions throughout Q1 of 2021. Deal volume increased by 121% (317 deals in 2020) and dollar volume increased a whopping 355% ($14.5 billion in 2020). We congratulate all the active members of the private placement community, many of whom are long- time clients of PlacementTracker. We are dedicated to providing access to the very best data and analytics available in our industry. Most Active Participants Include: • H.C. Wainwright & Co., LLC as the most active placement agent • Fidelity Management & Research Corporation as the most active institutional investor • Cooley LLP as the most active issuer counsel • Schulte Roth & Zabel, LLP as the most active investor counsel • Ellenoff Grossman & Schole LLP as the most active placement agent counsel • Jefferies & Company, Inc. as most active Agent for At-the Market (ATM) transactions • Yorkville Advisors, LLC as most active Investor for SEL transactions The Q1 2021 U.S. PIPE and Private Placement Markets Investment Banking League Table by Number of Transactions: Placement Agent Name Transaction Count Total Amount Placed H.C. Wainwright & Co., LLC 84 $3,948,120,633 A.G.P./Alliance Global Partners 38 $1,272,002,630 Oppenheimer & Co. Inc. 37 $4,340,669,297 Jefferies & Company, Inc. 36 $8,343,710,507 Cowen and Company, LLC 35 $5,439,335,451 Maxim Group LLC 34 $1,513,832,708 J.P.
    [Show full text]
  • Investor Presentation
    Investor Presentation For more information, please contact Tim Carter, chief financial officer at 612 303-5607 or timothy.carter@psc.com Piper Sandler Companies (NYSE: PIPR) is a leading investment bank and institutional securities firm driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Private equity strategies and fixed income advisory services are offered through separately registered advisory affiliates. © 2020. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036 Piper Sandler Investor Presentation Cautionary notice regarding forward-looking statements This presentation contains forward-looking statements. Statements that are not historical or current facts, including statements about beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and important factors could cause actual results to differ materially from those anticipated, including those factors identified in the document entitled “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019 and updated in our subsequent reports filed with the SEC. These reports are available at our Website at www.pipersandler.com and at the SEC Website at www.sec.gov. Forward-looking statements speak only as of the date they are made, and Piper Sandler undertakes no obligation to update them in light of new information or future events.
    [Show full text]
  • Global Equity Market Performance
    Weekly Equity Capital Markets Newsletter Piper Jaffray Asia Securities Limited April 19, 2010 Global Equity Market Performance Global Equity Market Update Piper Jaffray Asia Capital Markets Group U.S. stocks plunged on Friday amidst the heaviest trading activity J. West Riggs (Head of Asia ECM), j.west.riggs@pjc.com, Tel: (852) 3189 3230 in 2010, following the Securities and Exchange Commission’s fraud Derrick Lau (MD ECM), derrick.wy.lau@pjc.com, Tel: (852) 3189 3233 charges against Goldman Sachs. Disappointing earnings data and persistent uncertainty over Greece’s ability to pay its debts also Michael Cheung (Principal), michael.p.cheung@pjc.com, Tel: (852) 3189 3212 discouraged optimism over global economic recovery. During the week, Dow was up 0.2 percent to 11,018.7, NASDAQ gained 1.1 Amanda Lui (Associate), amanda.my.lui@pjc.com, Tel: (852) 3189 3296 percent to close at 2,481.3 while the S&P 500 closed 0.2 percent Henry Tseung (Analyst), henry.hw.tseung@pjc.com, Tel: (852) 3189 3298 lower at 1,192.1. Crude futures closed at $83.2 per barrel, down 2.0 percent over the week. Global Market Performance European stocks ended the week lower, as banking stocks reacted Performance (%) to the fraud charges leveled by the U.S. Securities and Exchange Commission against Goldman Sachs. The euro slid amidst worries Last price 1day 1week 1month YTD over Greece’s debt crisis while airline stocks weakened as Icelandic Global Indices volcanic ash caused air travel chaos across Europe . The DJ Euro Stoxx 50 closed down 1.5 percent at 2,949.7.
    [Show full text]
  • 2013 Capital Markets Year in Review
    2013 Capital Markets Year in Review January 2014 PIPER JAFFRAY CAPITAL MARKETS Since 1895. Member FINRA, NYSE, and SIPC. © 2014 Piper Jaffray & Co. piperjaffray.com Table of Contents Section I 2013 Year in Review Section II IPO Market Review Section III Follow-on Offering Market Review SiSection IV CfidillConfidentially MkdMarketed FllFollow-on (URD), Reg istere d Direct & PIPE Market Review Section V Convertible Market Review Appendix A Piper Jaffray Credentials 1 Section I 2013 Year in Review 2013 Year in Review 2013 Global Index Performance 2003 - 2012 Global Index Performance Japan (Nikkei) 57% India (Sensex) 475% U.S. (Nasdaq) 38% Brazil (Bovespa) 441% U.S. (Russell 2000) 37% Russia (RTS) 325% U.S. (S&P 500) 30% Hong Kong (Hang Seng) 143% U.S. (Dow Jones) 26% U.S. (Nasdaq) 126% Australia (ASX) 15% U.S. (Russell 2000) 122% U. K. (FTSE) 14% Canada (Toronto) 88% Canada (Toronto) 10% China (Shanghai) 67% India (Sensex) 9% U.S. (S&P 500) 62% Hong Kong (Hang Seng) 3% U.S. (Dow Jones) 57% Russia (RTS) -6% Australia (ASX) 54% China (Shanghai) -7% U.K. ()(FTSE) 50% -15% Brazil (Bovespa) Japan (Nikkei) 21% -20% -10% 0% 10% 20% 30% 40% 50% 60% 0% 100% 200% 300% 400% 500% 2013 S&P 500 Subsector Performance 2003 - 2012 S&P 500 Subsector Performance Cons. Disc 41% Energy 192% Health Care 39% Info Tech 110% Industrials 38% Cons. Disc 107% Financials 33% Materials 94% S&P 500 30% Utilities 82% IfInfo Tec h 26% Cons. StlStaples 76% Cons. Staples 23% Industrials 72% Materials 23% S&P 500 62% Energy 22% Health Care 50% Utilities 9% Financials -26% -10% 0% 10% 20% 30% 40% 50% -50% 0% 50% 100% 150% 200% 250% Source: Capital IQ Returns stated in each country’s local currency 3 2013 Year in Review 2013 marked the best U.S.
    [Show full text]